The 2026 Medicare Drug List: What’s Included and How to Navigate the Changes

A significant shift in how Medicare pays for prescription drugs is now in effect. If you’re on Medicare and take regular medications, you’ve likely heard about the 2026 price negotiations. It’s a core part of the Inflation Reduction Act of 2022, a law designed to tackle healthcare costs. For many, it raises a pressing question: “What does this actually mean for pharmacy bill?”

This article walks you through the 2026 Medicare Drug Price Negotiation List: what it is, which drugs are on it, and—most importantly—understand its potential impact.

What Is This “Negotiation Program” Anyway?

In a major policy change, the Centers for Medicare & Medicaid Services (CMS) can now directly negotiate prices with drugmakers for certain high-cost medications. Before this, federal law prohibited Medicare from doing so.

The program targets medications that meet specific criteria:

• Account for significant spending in Medicare
• Lack generic or biosimilar competition
• Have been on the market for a number of years

The goal is to establish a “maximum fair price” for these selected drugs.

The First 10 Drugs with Negotiated Prices (Effective 2026)

The inaugural list includes 10 common Part D drugs that represent a large share of Medicare’s prescription spending. They were chosen based on total cost to the program, not just their per-bottle price.

• Eliquis (apixaban)
• Enbrel (etanercept)
• Entresto (sacubitril/valsartan)
• Farxiga (dapagliflozin)
• Fiasp & NovoLog (insulin aspart products)
• Imbruvica (ibrutinib)
• Januvia (sitagliptin)
• Jardiance (empagliflozin)
• Stelara (ustekinumab)
• Xarelto (rivaroxaban)

The new, negotiated prices for these drugs took effect on January 1, 2026.

This Is Just the Start: What’s Coming in 2027 and Beyond

Think of the 2026 list as Phase 1. The program is designed to expand:

• 2027-2028:​ More drugs under Medicare Part D and Part B (which covers doctor-administered drugs) will be added.
• By 2029:​ Dozens of medications are expected to be part of the program.

Will This Lower Costs? Here’s What to Understand.

While the program aims to reduce system-wide spending, your personal out-of-pocket costs depend on several factors:

• Your specific Medicare plan (Part D or a Medicare Advantage plan)
• Your plan’s formulary (drug list), tiers, and cost-sharing rules
• The specific medications you take

Here’s a key point:​ For many people, another part of the Inflation Reduction Act might have a more direct and noticeable effect—the cap on annual out-of-pocket drug costs. In 2026, that cap is set at $2,100. Once you reach that limit for covered medications, your costs for the rest of the year drop significantly.

Which Drugs Are Not on the List?

Not every medication is eligible. Current exclusions include certain drugs for rare diseases, lower-cost medications, plasma-derived therapies, and some products from small biotech companies. These exclusions reflect policy balances between cost, innovation, and access.

What to Explore Next After Reading This

After getting the basics down, most people naturally want to know more. Here are the most common follow-up questions and how you can find answers:

• “How do I know what I’ll actually pay?”​ A practical first step is to use the official Medicare Plan Finder tool​ during the next Open Enrollment Period. This allows you to compare plans in your area with the most current drug pricing.
• “Do these changes affect Medicare Advantage plans the same way?”​ Yes, the negotiated prices apply. However, your final cost share can vary by plan. Checking your plan’s Annual Notice of Change or calling them directly is the best move.
• “How do drug tiers and formularies work with this?”​ A plan’s formulary determines your cost. A drug with a negotiated price could be placed on a different tier, affecting your copay. Reviewing your plan’s formulary is essential.
• “Should I switch plans?”​ That’s a personal decision based on your medications, pharmacy, and budget. The Plan Finder​ tool is designed to help with that comparison.

Where to Focus Research for a Complete Picture

Medicare is complex. To truly understand how these pieces fit together, people often research these questions:

• How to effectively review and compare Medicare Part D plans.
• Key dates and actions for the Medicare Annual Enrollment Period.
• The difference between coverage under Part B (doctor’s office) and Part D (pharmacy).
• Available financial assistance programs like Extra Help.

Conclusion

The 2026 Medicare Drug Price Negotiation List is a major development, but its real-world impact on you depends on your individual circumstances. It’s one part of a larger, evolving system.

Arming yourself with knowledge about how the program works is the best first step. It transforms you from a passive observer into an informed participant in your healthcare. With this foundation, you’re better prepared to ask the right questions—whether you’re using online tools, talking to your plan, or consulting with a professional.